Israeli-managed Code Pharma developed its Codivir treatment for HIV at its Israeli R&D center. It has just completed a successful Phase 1 trial in Brazil for using Codivir against the coronavirus and has applied to start a Phase 2 trial on 150 patients in Israel, Spain, Brazil and South Africa.
HIV therapy counters Covid-19
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.